Repeated gastroscopies at impendent relapse of bleeding from gastroduodenal ulcers
Abstract
Aim of investigation. To estimate necessity and potentials of dynamic esophagogastroduodenoscopies (EGDS) at successful primary hemostasis in patients with high risk of relapse of bleeding.
Material and methods. Retrospective analysis of case records of 332 patients hospitalized for bleeding from chronic stomach and duodenum ulcers was carried out. Evaluation of results in 122 patients after repeated EGDSs was carried out with account to causes of inefficiency of previous investigations.
Results. Repeated gastroscopies were caused by: relapse of bleeding – in 21 (17,2%) patient, of them in 81% of cases it developed within first 3 days after primary examination, non-informative initial EGDS – in 12 (9,8%), control gastroscopy in dynamics – in 89 (73%). Frequently the bleeding relapses in early terms educed due to ineffective endoscopic hemostasis at active bleedings or absence of prophylaxis at high risk of relapse (Forrest IIA-IIB) at previous gastroscopy. Control gastroscopies in 55 (62%) patients were performed in 1 day after primary investigation that allowed in 6 patients with high risk of bleeding relapse to reveal active recurrent bleeding before its clinical manifestation. In 39 (32 %) patients further required repeated gastroscopies, 17 (14%) patients were urgently operated in relation to ineffective endoscopic hemostasis or high risk of bleeding relapse at repeated EGDSs. Of all patients 19 died (15,6%), of them 5 – in postoperative period.
Conclusions. Principal causes of repeated gastroscopies were relapses of bleeding in early period after primary hemostasis and ineffective investigations. Relapses of ulcerative bleeding develop mostly in the first 3 days after primary hemostasis. At clinically significant relapses repeated gastroscopy with preventive actions is proven in patients with high operational risk on concomitant diseases (4–5 points by ASA scale). Repeated endoscopic investigations have no significant effect on clinical results of treatment of ulcerative bleedings, frequency of relapses, operative activity, mortality.
About the Authors
V. A. StupinRussian Federation
S. V. Siluyanov
Russian Federation
M. B. Sokhikyan
Russian Federation
R. Yu. Tronin
Russian Federation
R. Sh. Sardarov
Russian Federation
References
1. Шапошников А.В. Язвенная болезнь. Статистические наблюдения // Рос. журн. гастроэнтерол. гепатол. колопроктол. (Материалы Тринадцатой Российской Гастроэнтерологической Недели 22–24 октября 2007 г., Москва). – 2007. – Т. 17, № 5. – C. 39.
2. Bardou M., Toubouti Y., Benhaberou-Brun D. et al. High dose proton pump inhibition decrease both rebleeding and mortality in high-risk patients with acute peptic ulcer bleeding. A series of meta-analyses // Gastroenterology. – 2003. – Vol. 123. – P. 625.
3. Bardou M., Youssef M., Toubouti Y. et al. Newer endoscopic therapies decrease both re-bleeding and mortality in high risk patients with acute peptic ulcer bleeding: a series of meta-analyses // Gastroenterology. – 2003. – Vol. 123. – P. 239.
4. Barkun A., Bardou M., Marshall J.K. Managing patients with nonvariceal upper gastrointestinal bleeding // Ann. Med. – 2003. – Vol. 139, N 10. – P. 843–857.
5. Barkun A.N., Chiba N., Enns R. et al. Use of a national endoscopic database to determine the adoption of emerging pharmacological and endoscopic technologies in the everyday care of patients with upper GI bleeding: the RUGBE initiative // Am. J. Gastroenterol. – 2001. – Vol. 96. – P. 261.
6. Cook D.J., Guyatt G.H., Salena B.J., Laine L.A. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis // Gastroenterology. – 1992. – Vol. 102. – P. 139–148.
7. Hamoui N., Docherty S.D., Crookes P.F. Gastrointestinal hemorrhage: is the surgeon obsolete? // Emerg. Med. Clin. North. Am. – 2003. – Vol. 21, N 4. – P. 1017–1056.
8. Messmann H., Schaller P., Andus T. et al. Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial // Endoscopy. – 1998. – Vol. 30. – P. 583–589.
9. Rutgeerts P., Rauws E., Wara P. et al. Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer // Lancet. – 1997. – Vol. 350. – P. 692–696.
10. Sacks H.S., Chalmers T.C., Blum A.L. et al. Endoscopic hemostasis. An effective therapy for bleeding peptic ulcers // JAMA. – 1990. – Vol. 264. – P. 494–499.
11. Saeed Z.A., Cole R.A., Ramirez F.C. et al. Endoscopic retreatment after successful initial hemostasis prevents ulcer rebleeding: a prospective randomized trial // Endoscopy. – 1996. – Vol. 28. – P. 288–294.
12. Tsoi K., Chan H., Chiu P. et al. Second-look endoscopy with thermal coagulation or injections for peptic ulcer bleeding: A meta-analysis // J. Gastroenterol. Hepatol. – 2010. – Vol. 25. – P. 8–13.
13. Villanueva C., Balanzo J., Torras X. et al. Value of second-look endoscopy after injection therapy for bleeding peptic ulcer: a prospective and randomized trial // Gastrointest. Endosc. – 1994. – Vol. 40. – P. 34–39.
Review
For citations:
Stupin V.A., Siluyanov S.V., Sokhikyan M.B., Tronin R.Yu., Sardarov R.Sh. Repeated gastroscopies at impendent relapse of bleeding from gastroduodenal ulcers. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2011;21(6):12-18. (In Russ.)